The Ingenium Group Blog Top 10 U.S. patent losses of 2017

BY Eric Sagonowsky - FIERCEPHARMA Associate Editor Among the many meds that'll lose patent protection in the U.S. this year are 10 drugs that each contribute in a big way for top drugmakers. Eli Lilly, Pfizer, Takeda, Bristol-Myers Squibb and Gilead are each set to hit the patent cliff this year with some of their